Inventor · disambiguated record
Baiteng Zhao
Also filed as: ZHAO BAITENG
0 granted patents·12 pending applications·0 citations·filing 2015–2025
Top patents by PatentIndex Score
12 records- 0175US2024245796A1Linkers, drug linkers and conjugates thereof and methods of using the samePROFOUNDBIO US CO·Filed 2024·Application pending·0 cites
- 0275US2024261427A1Linkers, drug linkers and conjugates thereof and methods of using the samePROFOUNDBIO US CO·Filed 2024·Application pending·0 cites
- 0373US2024207429A1Linkers, drug linkers and conjugates thereof and methods of using the samePROFOUNDBIO US CO·Filed 2023·Application pending·0 cites
- 0473US2024207418A1Linkers, drug linkers and conjugates thereof and methods of using the samePROFOUNDBIO US CO·Filed 2023·Application pending·0 cites
- 0569US2025115680A1Ptk7 binding agents, conjugates thereof and methods of using the samePROFOUNDBIO US CO·Filed 2024·Application pending·0 cites
- 0667US2024076402A1Humanized anti-liv1 antibodies for the treatment of breast cancerSEAGEN INC·Filed 2023·Application pending·0 cites
- 0761US2025066490A1Anti-cd70 antibodies, conjugates thereof and methods of using the samePROFOUNDBIO US CO·Filed 2022·Application pending·0 cites
- 0856US2020283540A1Humanized anti-liv1 antibodies for the treatment of breast cancerSEATTLE GENETICS INC·Filed 2018·Application pending·0 cites
- 0948US2025381289A1Egfr and c-met bispecific binding agents, conjugates thereof and methods of using the sameGENMAB AS·Filed 2025·Application pending·0 cites
- 1042US2025296992A1Slitrk6 binding agents, conjugates thereof and methods of using the sameGENMAB AS·Filed 2025·Application pending·0 cites
- 1132US2024209080A1Folr1 binding agents, conjugates thereof and methods of using the samePROFOUNDBIO US CO·Filed 2022·Application pending·0 cites
- 1231US2017182178A1Optimal dosing of a cd19-antibody drug conjugateSEATTLE GENETICS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Baiteng Zhao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →